I initiate coverage on Haleon with a "hold" rating due to decent results and potential for ongoing growth, despite a slight revenue slip last year. Haleon's dividend grew 10% and is well-covered ...

Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five per cent. However, revenue declined by 0.6 per cent on a reported basis ...

Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands ...

Shares of HLN opened at $10.45 on Wednesday. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a 50-day moving average price of $9.66 and a two-hundred day moving ...

Wide-moat Haleon reported solid fourth-quarter earnings that came largely in line with our expectations. Total sales of GBP 2.8 billion was down 0.3% but was up 6.8% organically with 2.7% from ...